Derrick Collier
Nurse Practitioner · Cordele, GANPI 1386167112
Payments from drug & device makers
Across 378 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$986
- Novo Nordisk$871
- AbbVie$808
- Amgen$652
- GSK$544
- Johnson & Johnson$265
- plus $2K from 31 others
What the payments were for
- Food & beverage$6,25198%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$124
How this compares
$6,350 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $108,782 |
| JardianceEmpagliflozin | 95 | $91,728 |
| MounjaroTirzepatide | 68 | $75,664 |
| FarxigaDapagliflozin Propanediol | 75 | $50,684 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $44,602 |
| VraylarCariprazine Hcl | 29 | $41,432 |
| EliquisApixaban | 47 | $36,908 |
| LinzessLinaclotide | 46 | $35,367 |
| TrulicityDulaglutide | 20 | $32,621 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 41 | $26,798 |
| UbrelvyUbrogepant | 22 | $23,818 |
| CreonLipase/Protease/Amylase | 15 | $22,411 |
| XareltoRivaroxaban | 19 | $19,640 |
| TradjentaLinagliptin | 20 | $19,218 |
| Nurtec OdtRimegepant Sulfate | 12 | $18,004 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $871 | $124,55392 claims |
| AbbVieVraylar, Linzess, Ubrelvy, Creon | $808 | $123,029112 claims |
| Boehringer IngelheimJardiance, Tradjenta | $202 | $110,945115 claims |
| Lilly USA, LLCMounjaro, Trulicity | $259 | $108,28688 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $986 | $83,664130 claims |
| PfizerEliquis, Nurtec Odt | $135 | $54,91259 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $544 | $49,19170 claims |
| Johnson & JohnsonXarelto | $265 | $19,64019 claims |
| Astellas Pharma US IncMyrbetriq | $55 | $9,07821 claims |
| NovartisEntresto | $227 | $8,60112 claims |
| MerckBelsomra | $81 | $4,91711 claims |
| Sanofi-aventis U.S. LLCLantus | $103 | $2,67017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Cordele
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.